Search
DCVax-L; autologous dendritic cell vaccine
Indications:
- glioblastoma, adjunct to standard therapy
Adverse effects:
- similar to standard therapy
General
vaccine
Immunotherapy
References
- Liau LM, Ashkan K, Tran DD et al
First results on survival from a large Phase 3 clinical trial
of an autologous dendritic cell vaccine in newly diagnosed
glioblastoma.
Journal of Translational Medicine. 2018. 16:142
PMID: 29843811 Free PMC Article
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6